Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
Go back to Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences| (NASDAQ: KOD) | Delayed: 37.78 +0.73 (1.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.05 | 52 Week High | $ | |||
| Open | $37.12 | 52 Week Low | $ | |||
| Day High | $38.34 | P/E | N/A | |||
| Day Low | $37.03 | EPS | $ | |||
| Volume | 58,357 | |||||
